Tag:
Antigen Express
Latest Headlines
Latest Headlines
Antigen Express vaccine cuts breast cancer recurrence
Generex Biotechnology subsidiary Antigen Express has reported promising early results in a Phase II trial of its breast cancer treatment. The vaccine, called AE37, cut the recurrence of breast cancer
Generex unit expands AE37 study
Antigen Express, the vaccine subsidiary of Generex Biotechnology, has amended an agreement with the Henry M. Jackson Foundation for the Advancement of Military Medicine related to the ongoing Phase
